Researchers have developed innovative degradable phase change microcapsules to replace environmentally harmful microplastics in medical and industrial applications. Specifically, these new capsules utilize lactic acid-based materials to improve environmental safety. Traditional phase change materials often contribute to microplastic pollution. Therefore, this advancement addresses critical environmental health concerns while maintaining high efficiency in thermal storage.

Consequently, the scientific team utilized PLA diol (PLA-500) and other degradable wall materials via an interfacial polymerization method. This process encapsulates n-octadecane, a core material known for its thermal management properties. Furthermore, the researchers optimized the preparation process through rigorous experimentation. They discovered that a core-to-shell ratio of 4:1 results in the best performance. These degradable phase change microcapsules exhibit uniform particle size and excellent morphology.

Clinical Utility of Degradable Phase Change Microcapsules

Moreover, the thermal properties of these capsules are highly impressive. The prepared materials achieved a high phase change thermal storage capacity with a melting enthalpy of 171.9 J/g. Additionally, the lactic-acid-based shell ensures that the capsules degrade naturally after their functional life. This is particularly relevant for pharmacy and multispecialty medicine, where thermal regulation is vital for drug delivery and vaccine storage. In contrast to standard plastic shells, these materials reduce the long-term ecological footprint of medical supplies. Thus, they provide a dual benefit of high-performance thermal regulation and environmental sustainability.

How do these microcapsules degrade?

The microcapsules utilize PLA diol-modified materials in their shell. This lactic-acid-based structure allows for natural degradation, which significantly reduces the risk of long-term microplastic pollution in the environment.

What is the thermal capacity of this new material?

The optimized microcapsules demonstrate a melting enthalpy of 171.9 J/g. This high capacity ensures they can store and release significant amounts of heat, making them ideal for temperature-sensitive medical applications.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Zou T et al. Preparation and Characterization of Degradable Lactic-Acid-Based Phase Change Microcapsules. Langmuir. 2026 Apr 08. doi: 10.1021/acs.langmuir.5c05870. PMID: 41950516.

2. Qiu X et al. Applications of phase change materials in smart drug delivery for cancer treatment. Frontiers in Bioengineering and Biotechnology. 2020;8:561494.

3. Anayurt N & Alkan C. Recent applications of microencapsulated phase change materials. Journal of Naval Sciences and Engineering. 2021;10(1):24-37.